Owens & Minor presented Q2 FY22 earnings with a mixed result throughout the P&L. We rate OMI neutral and price the stock at $25.84. Click to read why.

Owens & Minor found using ticker (OMI) have now 5 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 62 and 43 calculating the average target price we see 52.8. With the stocks previous close at 32.42 this indicates there is a potential upside of 62.9%. The 50 day moving average now sits at 33.11 and the 200 day moving average is 39.19. The company has a market capitalisation of $2,486m. Visit the company website at: https://www.owens-minor.com [stock_market_widget type="chart" template="basic" color="green" assets="OMI" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,050m based on the market concensus. Owens & Minor, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.

The following slide deck was published by Owens & Minor, Inc.

Owens & Minor, Inc. (NYSE:NYSE:OMI) Q2 2022 Earnings Conference Call August 3, 2022 8:00 AM ET Company Participants Alex Jost – Director-Investor Relations Ed Pesicka – President and…

Owens & Minor Inc (NYSE: OMI I ) reported second-quarter revenue of $2.50 billion, an increase of 0.44% year-over-year , missing the consensus of $2.54 billion. Adjusted EPS of $0.76 in Q2 was lower than $1.06 a year ago, matching the consensus of $0.76. Gross margin expanded by 523 bps to 21.3%. Adjusted operating income declined 1.7% Y/Y to $113.6 million, and the margin was 4.5%, down by 10 bps. Patient Direct revenue grew 145% Y/Y to $573 million, with Byram revenue growth of 17% and Apria pro forma up 4.4%. Products & Healthcare Services revenue was … Full story available on Benzinga.com

Owens & Minor (NYSE: OMI ) reported its Q2 earnings results on Wednesday, August 3, 2022 at 06:45 AM. Here''s what investors need to know about the announcement. Earnings Owens & Minor reported in-line EPS of $0.76 versus an estimate of … Full story available on Benzinga.com

Owens & Minor press release (OMI): Q2 Non-GAAP EPS of $0.76 misses by $0.02.Revenue of $2.5B (+0.4% Y/Y) misses by $30M.The company’s outlook for 2022 is subject to the key…

Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the second quarter ended June 30, 2022, as summarized in the table below.

Owens & Minor (OMI) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, before market open.The consensus EPS Estimate is $0.78 (-26.4% Y/Y) and the consensus…

Owens & Minor with ticker code (OMI) have now 5 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 70 and 43 calculating the mean target price we have 55.6. Now with the previous closing price of 35.33 this indicates there is a potential upside of 57.4%. The 50 day moving average now sits at 33.16 and the 200 day MA is 39.14. The company has a market capitalisation of $2,718m. Company Website: https://www.owens-minor.com [stock_market_widget type="chart" template="basic" color="green" assets="OMI" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,277m based on the market concensus. Owens & Minor, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.

Owens & Minor with ticker code (OMI) now have 5 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 70 and 43 calculating the average target price we see 57. With the stocks previous close at 34.6 this is indicating there is a potential upside of 64.7%. There is a 50 day moving average of 33.2 and the 200 day MA is 39.04. The market cap for the company is $2,671m. Find out more information at: https://www.owens-minor.com [stock_market_widget type="chart" template="basic" color="green" assets="OMI" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $4,400m based on the market concensus. Owens & Minor, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.

RICHMOND, Va.--(BUSINESS WIRE)--Owens & Minor Announces Second Quarter 2022 Earnings Release Date

The OWENS & MINOR, INC. POLITICAL ACTION COMMITTEE (OWENS & MINOR PAC) successfully filed their F3XN JULY MONTHLY with the coverage period of 06/01/2022 to 06/30/2022 and a confirmation ID of FEC-1617018 *********CommitteeId: C00769810 | FilingId: 1617018 | FormType: F3XN | CoverageFrom: 06/01/2022 | CoverageThrough: 06/30/2022 | ReportType: JULY MONTHLY*********